CClinicalTrials.gg
Sign In
RecruitingNCT06179810Updated Dec 22, 2023

Effect of Baduanjin Exercise on Metabolic Syndrome Patients

An interventional study of Baduanjin exercise in Metabolic Syndrome, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 60 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-22.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled May 2023, registered Dec 2023).
  • Started May 2023; still recruiting 3 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
60 Years to 75 Years
Sex
All
01

Study summary

Pre/posttest randomized control trial design.

In this study all patients will be randomly assigned into two groups (30 in each group) :

  • Group A will do baduanjin exercise in addition to traditional medical treatment.
  • Group B will take traditional medical treatment only.
02

Conditions studied

  • Metabolic Syndrome
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 1,460 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • metabolic syndrome patients

Exclusion criteria

Exclusion Criteria:

  • patients with Respiratory diseases
  • patients with pacemaker patients
  • patients with Neurological diseases
  • patients with orthopedic diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Baduanjin exercise in addition to medical treatment

    30 patients with metabolic syndrome do baduanjin exercise in addition to traditional medical treatment

    Other: Baduanjin exercise

  • Experimental
    Traditional medical treatment

    30 patients with metabolic syndrome taking traditional medical treatment

    Other: Baduanjin exercise

Interventions

  • OtherBaduanjin exercise

    Baduanjin exercise

06

What researchers measure

Primary outcomes

  1. Fasting glucose level

    Pre/post fasting glucose level in blood

    Time frame: 3 months

  2. Lipids profile

    Pre/post HDL \& lDL levels in blood

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Ahmed Mohamed Abdelrahman Eldeeb
    Cairo, Qaliop Elbalad, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06179810
Lead sponsor
Cairo University
Responsible party
Ahmed eldeeb (EFFECT OF BADUANJIN EXERCISE ON QUALITY OF LIFE IN PATIENTS WITH METABOLIC SYNDROME, Cairo University) — Principal investigator
First posted
Dec 22, 2023
Start date
May 15, 2023
Primary completion
Dec 15, 2023 (estimated)
Completion
Dec 15, 2023 (estimated)
Last update
Dec 22, 2023

Study contacts

Ahmed Mohamed Eldeeb, Master
Contact
eldeebahmed2018@gmail.com
01153278847

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Metabolic Syndrome→

Other studies from this sponsor

Cairo University

Start the discussion